See also this year's filing and all EDGAR filings for this company.
PDF Report 0001333248_2014_Cadence_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001333248, Cadence Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 77,888,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 10,747,000 |
| 2 | PropertyPlantAndEquipmentNet | 2,060,000 |
| 3 | remainder_Assets | 108,000 |
| 4 | LiabilitiesCurrent | 36,543,000 |
| 5 | LiabilitiesNoncurrent | 19,382,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 94,482,000 |
| 9 | ResearchAndDevelopmentExpense | 6,743,000 |
| 10 | remainder_Expenses | 38,875,000 |
| 11 | remainder_Revenues | 112,556,000 |
| 12 | remainder_NetIncome | 3,250,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 90,803,000 |
| 1 | Liabilities | 55,925,000 |
| 2 | Expenses | 140,100,000 |
| 3 | Revenues | 112,556,000 |
| 4 | StockholdersEquity | 34,878,000 |
| 5 | NetIncome | -24,294,000 |
| 6 | ComprehensiveNetIncome | -24,294,000 |
| 7 | BaseVar | 201,317,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.705 |
| 9 | EconomicCapitalRatio | 2.06 |
Edgar->Model Mapping
Feature Distribution
Change over Time
